cholestyramine resin has been researched along with zidovudine in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 10,180 | 1,399 | 1,188 |
| Protein | Taxonomy | cholestyramine resin (IC50) | zidovudine (IC50) |
|---|---|---|---|
| Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
| Protease | Human immunodeficiency virus 1 | 0.015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkelstein, MO; Levin, B; Robbins, H | 1 |
1 other study(ies) available for cholestyramine resin and zidovudine
| Article | Year |
|---|---|
Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples.
Topics: Acquired Immunodeficiency Syndrome; Cholesterol; Cholestyramine Resin; Controlled Clinical Trials as Topic; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Humans; Male; Models, Statistical; Patient Selection; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Risk Factors; Survival Analysis; Zidovudine | 1996 |